TanyaZarembaFischerMD
Neurology • West Haven, CTAssistant Professor, Neurology, Yale University School of Medicine
Dr. Fischer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave
Building 34
West Haven, CT 06516Phone+1 203-932-4724Fax+1 203-937-3464
Education & Training
Yale-New Haven Medical CenterResidency, Neurology, 2003 - 2006
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2002 - 2003
Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
CT State Medical License 2006 - 2025
Publications & Presentations
PubMed
- 27 citationsEffect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.Sonja Krösser, Peter Wolna, Tanya Fischer, Ursula Boschert, Randall Stoltz
Journal of Clinical Pharmacology. 2015-09-01 - 19 citationsCumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1aAli-Frédéric Ben-Amor, Anton Trochanov, Tanya Fischer
Advances in Therapy. 2015-05-20 - 7 citationsNeuropathic pain in two-generation twins carrying the sodium channel Nav1.7 functional variant R1150W.Judith U. Harrer, Nurcan Üçeyler, Kathrin Doppler, Tanya Z. Fischer, Sulayman D. Dib-Hajj
Pain. 2014-10-01
Press Mentions
Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s DiseaseFebruary 14th, 2017
Breast Cancer MetastaticDecember 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
